Now Live: Cboe Europe real-time data for all major European stocks.
closing in 4h 58m
Main market

STOCKS is currently active.
Closing in 4 hours 58 minutes

11:01
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).
314.26 USD
16.08
4.87%
Last update Apr 7, 10:58 AM EDT
Main market
Day range
313.78
318.57
Previous close
330.34000
Open
317.52
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
314.26
16.08
4.87%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 3.7B 2.2B 1.8B 1.0B
Cost of revenue 681.9M 323.4M 310.4M 168.8M
Gross profit 3.0B 1.9B 1.5B 868.6M
Operating expense
Research & development 1.3B 1.1B 1.0B 883.0M
Selling general and admin 1.2B 975.5M 795.6M 770.7M
Other operating expenses
Operating income 501.6M -176.9M -282.2M -785.1M
Non operating interest income
Income 111.5M 122.0M 95.6M 24.8M
Expense 252.6M 141.9M 121.2M 156.0M
Other income expense -37.3M -180.6M -125.7M -210.8M
Pretax income 323.2M -377.4M -433.5M -1.1B
Tax provision 9.4M -99.2M 6.7M 4.2M
Net income 313.7M -278.2M -440.2M -1.1B
Basic EPS 2.4 -2.2 -3.5 -9.3
Diluted EPS 2.3 -2.2 -3.5 -9.3
Basic average shares 131.0M 127.7M 124.9M 121.7M
Diluted average shares 131.0M 127.7M 124.9M 121.7M
EBITDA 676.2M -5.1M -107.3M -680.9M
Net income from continuing op. 313.7M -278.2M -440.2M -1.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan (individual) and the Venture plan (business) and above.
Main market

Exchange is currently active.
Closing in 4 hours 58 minutes

11:01
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).